SELLAS Life Sciences Group, Inc.
SLS
$7.68
-$0.30-3.76%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/9/2026
-
Tickeron - Stocks
A Look At SELLAS Life Sciences Group (SLS) Valuation After Arbitration And Phase 3 Regal Trial Hopes
6/8/2026
-
Simply Wall St
6/7/2026
-
Tickeron - Stocks
6/7/2026
-
Tickeron - Stocks
6/5/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
6/3/2026
-
Tickeron - Stocks
6/3/2026
-
Tickeron - Stocks
6/1/2026
-
Simply Wall St
5/31/2026
-
Simply Wall St
5/29/2026
-
Tickeron - Stocks
5/28/2026
-
SeekingAlpha
5/28/2026
-
Seeking Alpha - Healthcare
5/28/2026
-
The Cerbat Gem
5/27/2026
-
Tickeron - Stocks
5/27/2026
-
Tickeron - Stocks
5/26/2026
-
Simply Wall St
5/23/2026
-
Tickeron - Stocks
5/23/2026
-
Tickeron - Stocks
5/22/2026
-
SeekingAlpha
5/22/2026
-
Seeking Alpha - Healthcare
5/22/2026
-
Simply Wall St
5/21/2026
-
Stocktwits News Feed
5/20/2026
-
Benzinga
5/17/2026
-
Simply Wall St
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
646 200 5278
Address
7 Times Square
New York, NY 10036
New York, NY 10036
Country
Year Founded
--
Business Description
Sector
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The...
more